FOSUN HEALTH Logo

Pituitary Tumor Causes

catalogue

Pituitary Tumor Causes

Pituitary Tumor Causes

A pituitary tumour arises from the hormone-producing cells of the pituitary gland itself, which is why a tumour that keeps making its cell of origin's hormone raises that hormone. In most patients no cause can be identified: no diet, habit or environmental exposure has been shown to cause these tumours. In a minority the tumour is part of an inherited syndrome — multiple endocrine neoplasia type 1, familial isolated pituitary adenoma, or a change in the AIP gene — and those are suspected on age, family history or other tumours rather than assumed.

Where the tumour comes from

The origin of the tumour explains both what it is and why it behaves in two directions at once:

  • It arises from the gland's own cells — the cells of the front part of the pituitary that manufacture and release hormones. That is why the classification of these tumours follows the cell they came from, and why a tumour that continues to make its cell's hormone raises that hormone in the blood.
  • It grows inside a small bony hollow. The pituitary sits in a hollow at the base of the skull with the optic chiasm directly above, the cavernous sinus on either side, and the sphenoid sinus below. There is no room to spare, which is why even a small tumour can press on something that matters.
  • It is benign in the ordinary case — it does not spread, and it does not invade the brain. The clinical questions are about hormones and about pressure, which is why the vocabulary of cancer — spread, margins, stages — does not apply here.
  • It arises where the cells are, not where a cause was. There is no local factor to point to, and no history that predicts who will develop one.

What the hormone tells you about the tumour

The hormone a tumour produces is not incidental — it determines the disease it causes, and to some extent how the tumour behaves:

  • Prolactin-producing tumours raise prolactin, which suppresses the normal reproductive cycle. They are the commonest functioning tumours, and the one type for which medication is the first-line treatment.
  • Growth hormone-producing tumours cause acromegaly. They are usually treated with surgery first, with medication used to control the hormone where surgery is not sufficient.
  • ACTH-producing tumours drive the adrenal glands to make too much cortisol, causing Cushing's disease. Surgery is the usual first step, with medication used where surgery is not possible or not enough.
  • A raised prolactin does not always mean the tumour makes it. A tumour that compresses the stalk interrupts the signal that normally restrains prolactin, so the level rises without the tumour producing the hormone. The distinction matters because it changes the treatment, and it is one of the reasons a mild rise is interpreted with care.

The inherited syndromes

These account for a minority of pituitary tumours, and they deserve a precise account because recognising them changes the follow-up for life:

  • Multiple endocrine neoplasia type 1 — an inherited syndrome in which pituitary tumours may occur alongside tumours of the parathyroid and pancreatic glands. In this setting the pituitary tumour is sometimes the first manifestation, which is why a young patient with a pituitary tumour may be asked about other symptoms and about the family.
  • Familial isolated pituitary adenoma — pituitary tumours in more than one family member, without the other features of a named syndrome. It is recognised as its own entity, and its identification changes what relatives are offered.
  • AIP gene changes — associated with pituitary tumours presenting at a younger age and often with a family history; they make assessment and defined follow-up appropriate.
  • What a diagnosis changes — scheduled imaging and blood tests for the pituitary and for the other glands involved, for a lifetime; a lower threshold for investigating new symptoms; and information that matters to relatives, which a genetics service is the right place to arrange.

Age, sex and the way the tumour is found

Who these tumours are found in, and why the pattern differs between men and women:

  • Middle adult life — most pituitary tumours are diagnosed in adults in midlife, though they occur across a wide age range and inherited forms present considerably younger.
  • Prolactin-producing tumours are found differently in women and men — because a raised prolactin interrupts the menstrual cycle in women, it comes to attention early and often; in men the equivalent symptoms are quieter, so these tumours tend to be larger by the time they are found. This is a difference in when the tumour is noticed rather than in the disease itself.
  • Hormone-producing and non-functioning tumours differ in how they appear at all — a functioning tumour announces itself through its hormone; a non-functioning tumour has no such signal and waits until it presses on something.
  • None of this is a risk factor a person can act on. Age and sex describe when and in whom the tumour is found; they do not describe anything that could have been done differently.

Explanations that are not supported

Several widely repeated explanations can be set aside, and doing so is useful because it redirects attention to what can be acted on:

  • Stress and lifestyle. No diet, occupational exposure or environmental agent has been established as a cause of pituitary tumours, despite study.
  • Head injury. A blow to the head does not cause a pituitary tumour. It sometimes leads to a scan that finds one, and it can occasionally damage the gland itself — which is a different matter, and a common source of the misunderstanding.
  • Medication taken in the past. Patients often look back for something they took years earlier. No such link has been established, and the search usually delays attention to a finding that needs it now.
  • The hormone symptoms were caused by the tumour, not the other way round. Weight change, loss of periods or high blood pressure are consequences of the tumour producing a hormone, not the cause of it — which is worth stating because some patients assume their symptoms generated the tumour.
  • Supplements and herbal remedies. None has been shown to shrink a pituitary tumour, and some interact with the medication used to control the hormone, which makes taking them without discussion a real risk rather than a neutral choice.

Who is actually at risk

Putting the factors in one place, in order of how firmly they are established:

  • People with an inherited syndrome — multiple endocrine neoplasia type 1, familial isolated pituitary adenoma, or an AIP gene change. These are the groups with a defined surveillance programme, and they are a minority of all patients.
  • Adults in midlife — the period in which most sporadic tumours are diagnosed, though the reason is largely that this is when they are looked for.
  • People with a family history of pituitary tumours — a first-degree relative with a pituitary tumour is a reason for assessment rather than surveillance in everyone.
  • Everyone else — no lifestyle, occupational or environmental factor has been shown to change the risk, and nothing a person did or failed to do brought the tumour about.

Frequently Asked Questions

Did anything I did cause this?

No. No diet, occupational exposure or environmental agent has been established as a cause of pituitary tumours, and the factors that are recognised — inherited syndromes and adult midlife — are not things a person chooses or controls. Most patients have none of the recognised factors and no family history at all. It is worth saying plainly, because patients often search their history for something they might have taken or done, and that search costs time that is better spent on the scan, the hormone panel and the fields that decide the treatment.

Is it hereditary? Should my children be checked?

Usually not. The great majority of pituitary tumours are single, sporadic tumours in people with no family history, and they do not imply a risk to relatives — no imaging or blood-test surveillance is recommended for the relatives of an ordinary patient. What can be inherited are the syndromes: multiple endocrine neoplasia type 1, familial isolated pituitary adenoma, and AIP gene changes. Those are suspected when the tumour appears unusually young, when more than one family member is affected, or when other tumours are present, and a genetics service is the right place to arrange the assessment and the conversation with relatives.

Why did the tumour make a hormone in the first place?

Because it arose from a cell whose job was to make that hormone, rather than from a cell that made nothing. This is why the classification follows the cell of origin, and why the treatment differs so much between types: a prolactin-producing tumour responds to medication that acts on the same receptor the gland uses to control prolactin, whereas a growth hormone- or ACTH-producing tumour is usually treated surgically first. It also explains why a raised prolactin does not always mean the tumour produces it — a tumour pressing on the stalk can raise prolactin without making it, and that distinction changes what is done.

Can the hormone problem be cured by removing the tumour?

Often the hormone level falls after successful removal, and for a growth hormone- or ACTH-producing tumour that fall is part of how success is judged. But there are two qualifications worth knowing in advance. Where the tumour extended into the cavernous sinus or elsewhere it could not be fully reached, the hormone may remain high and require medication or radiation. And the operation can leave the gland itself producing too little, so replacement hormones may be needed afterwards. That is why the hormone panel is checked before every step and rechecked after it, rather than assumed.

Ask whether your family history changes anything

Send the MRI images and reports with dates, the hormone results with their reference ranges and dates, the visual field printouts, and a note of any family history of pituitary or other endocrine tumours. Our team will return a written assessment within 48 hours of the file being complete, including whether further genetic assessment or surveillance is indicated.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*